B&L leadership changes
This article was originally published in The Tan Sheet
Executive SummaryBausch & Lomb announces Jan. 5 it will realign management responsibilities for the Americas region, following current Senior VP Paul G. Howes' resignation announcement. Howes says he plans to pursue other career opportunities, but will remain with B&L to help transition to a new management structure. "One of the hallmarks of Paul Howes' tenure with Bausch & Lomb was his passionate focus on developing and maintaining excellent customer relationships," B&L Chairman and CEO Ronald L. Zarrella says...
You may also be interested in...
Phase III data earns a breakthrough therapy designation for Resverlogix’ apabetalone; previous companies to follow that strategy swiftly advance to NDA submission, as seen with Novartis’ capmatinib and Seattle Genetics’ tucatinib.
Pink Sheet analysis finds that evidence from early-stage trials supports most BTD requests, but about three in 10 designations are granted on the basis of pivotal-stage data.
Four House hearings show how far away even many Democrats are from supporting a single payer system in the US.